139 related articles for article (PubMed ID: 12219588)
1. ORS during the 2000-2001 influenza vaccination season.
Choudhri Y; Walop W; Squires S; Tam T; King A; Skowronski D; Warrington R; Wood J
Can Commun Dis Rep; 2002 Sep; 28(ACS-6):2-8. PubMed ID: 12219588
[No Abstract] [Full Text] [Related]
2. Supplementary statement for the 2002-2003 influenza season: update on oculo-respiratory syndrome in association with influenza vaccination.
Orr P
Can Commun Dis Rep; 2002 Sep; 28(ACS-6):1. PubMed ID: 12219587
[No Abstract] [Full Text] [Related]
3. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary Statement for the 2001-2002 season: influenza vaccination of persons who experienced oculo-respiratory syndrome following previous influenza vaccination.
National Advisory Committee on Immunization (NACI).
Can Commun Dis Rep; 2001 Nov; 27():1-7. PubMed ID: 11817153
[No Abstract] [Full Text] [Related]
4. Safety of revaccination of patients affected by the oculo-respiratory syndrome (ORS) following influenza vaccination.
Grenier JL; Toth E; De Serres G; Ménard S; Roussel R; Tremblay M; Landry M; Robert Y; Skowronski DM
Can Commun Dis Rep; 2004 Jan; 30(2):9-16. PubMed ID: 14964915
[No Abstract] [Full Text] [Related]
5. Oculo-respiratory syndrome following influenza vaccination: review of post-marketing surveillance through four influenza seasons in Canada.
Can Commun Dis Rep; 2005 Nov; 31(21):217-25. PubMed ID: 16669126
[No Abstract] [Full Text] [Related]
6. Oculo-respiratory syndrome: a new influenza vaccine-associated adverse event?
Skowronski DM; Strauss B; De Serres G; MacDonald D; Marion SA; Naus M; Patrick DM; Kendall P
Clin Infect Dis; 2003 Mar; 36(6):705-13. PubMed ID: 12627354
[TBL] [Abstract][Full Text] [Related]
7. Oculo-respiratory syndrome after influenza vaccination: trends over four influenza seasons.
De Serres G; Toth E; Ménard S; Grenier JL; Roussel R; Tremblay M; Landry M; Robert Y; Rochette L; Skowronski DM
Vaccine; 2005 May; 23(28):3726-32. PubMed ID: 15882534
[TBL] [Abstract][Full Text] [Related]
8. Randomized, double-blind, placebo-controlled trial to assess the rate of recurrence of oculorespiratory syndrome following influenza vaccination among persons previously affected.
Skowronski DM; De Serres G; Scheifele D; Russell ML; Warrington R; Davies HD; Dionne M; Duval B; Kellner J; MacDonald J
Clin Infect Dis; 2003 Oct; 37(8):1059-66. PubMed ID: 14523770
[TBL] [Abstract][Full Text] [Related]
9. Clinical manifestations and incidence of oculo-respiratory syndrome following influenza vaccination--Quebec, 2000.
Boulianne N; De Serres G; Duval B; Shadmani R; Rochette L
Can Commun Dis Rep; 2001 May; 27(10):85-90. PubMed ID: 11396047
[No Abstract] [Full Text] [Related]
10. Low risk of recurrence of oculorespiratory syndrome following influenza revaccination.
Skowronski DM; Strauss B; Kendall P; Duval B; De Serres G
CMAJ; 2002 Oct; 167(8):853-8. PubMed ID: 12406942
[TBL] [Abstract][Full Text] [Related]
11. Influenza vaccine oculorespiratory syndrome incidence is reduced in HIV.
Cooper C; Thorne A;
Vaccine; 2011 Oct; 29(45):7876-7. PubMed ID: 21872629
[TBL] [Abstract][Full Text] [Related]
12. Oculo-respiratory syndrome in association with the influenza vaccine: Canada, October-November 2000.
Can Commun Dis Rep; 2000 Dec; 26(23):201-2. PubMed ID: 11149349
[No Abstract] [Full Text] [Related]
13. Ophthalmological and biological features of the oculorespiratory syndrome after influenza vaccination.
Fredette MJ; De Serres G; Malenfant M
Clin Infect Dis; 2003 Oct; 37(8):1136-8. PubMed ID: 14523781
[TBL] [Abstract][Full Text] [Related]
14. Does antigen-specific cytokine response correlate with the experience of oculorespiratory syndrome after influenza vaccine?
Skowronski DM; Lu H; Warrington R; Hegele RG; De Serres G; HayGlass K; Stark D; White R; Macnabb J; Li Y; Manson HE; Brunham RC
J Infect Dis; 2003 Feb; 187(3):495-9. PubMed ID: 12552434
[TBL] [Abstract][Full Text] [Related]
15. Oculorespiratory syndrome after influenza immunization in children.
Skowronski DM; Bjornson G; Husain E; Metzger DL; Scheifele DW
Pediatr Infect Dis J; 2005 Jan; 24(1):63-9. PubMed ID: 15665712
[TBL] [Abstract][Full Text] [Related]
16. Recurrence risk of oculorespiratory syndrome after influenza vaccination: randomized controlled trial of previously affected persons.
De Serres G; Skowronski DM; Guay M; Rochette L; Jacobsen K; Fuller T; Duval B
Arch Intern Med; 2004 Nov; 164(20):2266-72. PubMed ID: 15534165
[TBL] [Abstract][Full Text] [Related]
17. Aggregate content influences the Th1/Th2 immune response to influenza vaccine: evidence from a mouse model.
Babiuk S; Skowronski DM; De Serres G; HayGlass K; Brunham RC; Babiuk L
J Med Virol; 2004 Jan; 72(1):138-42. PubMed ID: 14635022
[TBL] [Abstract][Full Text] [Related]
18. Skin testing to evaluate oculo-respiratory syndrome (ORS) associated with influenza vaccination during the 2000-2001 season.
Skowronski DM; De Serres G; Hebert J; Stark D; Warrington R; Macnabb J; Shadmani R; Rochette L; MacDonald D; Patrick DM; Duval B
Vaccine; 2002 Jun; 20(21-22):2713-9. PubMed ID: 12034097
[TBL] [Abstract][Full Text] [Related]
19. Oculo-respiratory syndrome following influenza vaccination: evidence for occurrence with more than one influenza vaccine.
De Serres G; Boulianne N; Duval B; Rochette L; Grenier JL; Roussel R; Donaldson D; Tremblay M; Toth E; Ménard S; Landry M; Robert Y
Vaccine; 2003 Jun; 21(19-20):2346-53. PubMed ID: 12744865
[TBL] [Abstract][Full Text] [Related]
20. Ocular and respiratory symptoms attributable to inactivated split influenza vaccine: evidence from a controlled trial involving adults.
Scheifele DW; Duval B; Russell ML; Warrington R; DeSerres G; Skowronski DM; Dionne M; Kellner J; Davies D; MacDonald J
Clin Infect Dis; 2003 Apr; 36(7):850-7. PubMed ID: 12652385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
